Synergistic activity of JAK2 and BCL-2 inhibition against B-cell acute lymphoblastic leukemia

被引:0
|
作者
Rinella, Sean [1 ]
Hess, Nicholas [1 ]
Bell, Haley [1 ]
Shi, Lei [1 ]
Rui, Lixin [1 ]
Capitini, Christian [1 ]
机构
[1] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA
基金
美国国家卫生研究院;
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e22002
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Bcl-2 cytofluorimetric expression in B-cell chronic lymphocytic leukemia.
    Raspadori, D
    Lauria, F
    Ventura, MA
    Rondelli, D
    Cimarelli, S
    Tura, S
    BLOOD, 1995, 86 (10) : 3353 - 3353
  • [42] Targeting BET proteins improves the therapeutic efficacy of BCL-2 inhibition in T-cell acute lymphoblastic leukemia
    Peirs, S.
    Frismantas, V.
    Matthijssens, F.
    Van Loocke, W.
    Pieters, T.
    Vandamme, N.
    Lintermans, B.
    Dobay, M. P.
    Berx, G.
    Poppe, B.
    Goossens, S.
    Bornhauser, B. C.
    Bourquin, J-P
    Van Vlierberghe, P.
    LEUKEMIA, 2017, 31 (10) : 2037 - 2047
  • [43] Targeting BET proteins improves the therapeutic efficacy of BCL-2 inhibition in T-cell acute lymphoblastic leukemia
    S Peirs
    V Frismantas
    F Matthijssens
    W Van Loocke
    T Pieters
    N Vandamme
    B Lintermans
    M P Dobay
    G Berx
    B Poppe
    S Goossens
    B C Bornhauser
    J-P Bourquin
    P Van Vlierberghe
    Leukemia, 2017, 31 : 2037 - 2047
  • [44] Novel Drugs to Target JAK2 Rearrangements in Pediatric Acute Lymphoblastic Leukemia
    Quadri, Manuel
    Saitta, Claudia
    Palamini, Sonia
    Palmi, Chiara
    Tu, Jia-Wey
    Bhatia, Sanil
    Borkhardt, Arndt
    Biondi, Andrea
    Cazzaniga, Giovanni
    Fazio, Grazia
    BLOOD, 2022, 140
  • [45] Effective tumor cell abrogation via Venetoclax-mediated BCL-2 inhibition in KMT2A-rearranged acute B-lymphoblastic leukemia
    Richter, Anna
    Lange, Sandra
    Holz, Clemens
    Brock, Luisa
    Freitag, Thomas
    Sekora, Anett
    Knuebel, Gudrun
    Krohn, Saskia
    Schwarz, Rico
    Hinz, Burkhard
    Escobar, Hugo Murua
    Junghanss, Christian
    CELL DEATH DISCOVERY, 2022, 8 (01)
  • [46] Effective tumor cell abrogation via Venetoclax-mediated BCL-2 inhibition in KMT2A-rearranged acute B-lymphoblastic leukemia
    Anna Richter
    Sandra Lange
    Clemens Holz
    Luisa Brock
    Thomas Freitag
    Anett Sekora
    Gudrun Knuebel
    Saskia Krohn
    Rico Schwarz
    Burkhard Hinz
    Hugo Murua Escobar
    Christian Junghanss
    Cell Death Discovery, 8
  • [47] Synergistic Activity of Combined Targeting of BCL-2 with MCL-1 or BCL-Xl in B-Cell Precursor All
    Seyfried, F.
    Stirnweiss, F.
    Niedermayer, A.
    Enzenmuller, S.
    Horl, R.
    Kohrer, S.
    Debatin, K. -M.
    Meyer, L.
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S161 - S161
  • [48] BAX/BCL-2 EXPRESSION IN CHILDHOOD AND ADOLESCENTS' ACUTE LYMPHOBLASTIC LEUKEMIA
    Stiakaki, Eftichia
    Kaparou, Maria
    Choumerianou, Despina
    Perdikogianni, Chryssoula
    Kalmanti, Maria
    PEDIATRIC BLOOD & CANCER, 2009, 53 (05) : 763 - 763
  • [49] BAX/BCL-2 EXPRESSION IN CHILDHOOD AND ADOLESCENTS' ACUTE LYMPHOBLASTIC LEUKEMIA
    Kaparou, M.
    Stiakaki, N.
    Choumerianou, D.
    Perdikogianni, C.
    Dimitriou, H.
    Kalmanti, M.
    EXPERIMENTAL HEMATOLOGY, 2009, 37 (09) : S45 - S46
  • [50] THE BCL-1 AND BCL-2 GENE IN CHILDHOOD B-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA
    TERADA, N
    KAWAHA, K
    TAWA, A
    YUMURAYAGI, K
    ISHIHARA, S
    MURATA, M
    IZUMI, Y
    YABUUCHI, H
    TSUJIMOTO, Y
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 177 - 177